GlassScriptPhysician profile
Moneim Elomeiri
NPI 1447614524
$17,136.81
in general payments reported to CMS, 2019-2025
13 companies · $3,724 in 2025
The $3,724 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $625 · 2023: $7,490 · 2024: $5,298 · 2025: $3,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $5,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,349.47 |
| Travel and Lodging | $5,162.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $9,058.96 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Abbvie INC. | $2,737.86 | 2023-2025 | |
| Tela Bio, INC. | $1,886.79 | 2024 | Ovitex 2s |
| Kerecis Limited | $1,202.73 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $877.92 | 2022-2025 | Restrata Wound Matrix |
| Mentor Worldwide LLC | $403.63 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Innovation Technologies INC | $333.31 | 2022-2024 | Irrisept |
| Polynovo North America LLC | $210.76 | 2022 | |
| Kls-Martin L.P. | $172.03 | 2022-2024 | |
| Avita Medical Americas, LLC | $114.12 | 2024 | |
| Integra Lifesciences Corporation | $83.41 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Motiva USA, LLC | $36.95 | 2025 | |
| Stryker Corporation | $18.34 | 2025 | Lifenet Adapter 64-Bit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moneim Elomeiri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.